AJCP / Meeting AbstrActs oxyhemoglobin to methemoglobin. We present a case of severe methemoglobinemia that resolved rapidly with red blood cell exchange (RBCX). The patient is a 57-year-old African-American woman with stage IV rectal adenocarcinoma, hepatitis C, arthritis, and bipolar disorder who was admitted to the hospital with a partial small bowel obstruction, for which she was treated conservatively. On hospital day five, the patient developed acute confusion and diaphoresis, and her oxygen saturation was noted to be 73%-75%. ABG was drawn, the blood was noted to be chocolate brown, and the methemoglobin level was too high to be quantitated (on three separate co-oximeters). The patient admitted to going through almost two bottles of HurriCaine spray (benzocaine) that morning for her sore throat. Methylene blue was considered for treatment, but the patient was on three different selective serotonin reuptake inhibitors at the time and there was concern for the precipitation of serotonin syndrome. Ascorbic acid was also considered, but the hospital did not have sufficient quantities on hand. The decision was made to proceed with RBCX. Using the Spectra Optia Apheresis system (Terumo BCT, Lakewood, CO), a 2.0 RBC volume RCBX was completed, using nine units of leukocyte-reduced type A positive packed red blood cells. Rinseback was not done. After the 108-minute uncomplicated procedure, the patient's methemoglobin level was 5.8%, and she subjectively felt much better and no longer had signs of cyanosis. Her O 2 saturation was 97% on 2L nasal cannula, and the methemoglobin level was 1.7% 11.5 hours after the RBCX. Fewer than 10 cases of RBCX for methemoglobinemia have been published. Objectives: A premature baby girl with a complicated hospital course developed RSV pneumonitis at 2 months of age for which she was placed on extracorporeal membrane oxygenation (ECMO). In spite of earlier phototherapy, bilirubin was steadily increasing and reached 50.4 mg/dL with concern for bilirubin induced neurologic dysfunction. Exchange transfusion was not recommended due to patient instability and risk of significant deterioration while on ECMO. Plasma exchange (PLEX), although not a recognized as a category treatment option for hyperbilirubinemia by the American Society for Apheresis (ASFA), was suggested as an alternative management option. We present a case of successful management of hyperbilirubinemia by PLEX in a premature baby while on ECMO. Methods: PLEX was done via connection with the ECMO circuit. Parameters were appropriately adjusted for the small body weight and ECMO circuit. For the procedure we used all fresh frozen plasma with plasma volume exchange between 1.0 and 1.3. We also primed the apheresis machine with packed red blood cells to minimize volume loss in tubing systems. Results: A total of three procedures were done daily and resulted in rapid improvement and stabilizing of bilirubin level. The procedure was very effective and well tolerated. Despite stabilizing the bilirubin level, the patient ultimately expired due to her underlying medical condition. Conclusion: This case is unique because of the use of PLEX on premature baby of 3.4 kg, but also because of use of ECMO as the point of access. In addition this case highlights that PLEX can be successfully used in this unique patient population as well as for management of hyperbilirubinemia in this patient group. The use of PLEX should be considered in premature babies complicated by extreme hyperbilirubinemia that are not candidates for standard treatment options to prevent further worsening of kernicterus and gain fast correction of bilirubin values.
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Successful Use of Plasmapheresis for Hyperbilirubinemia in a Premature
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Therapeutic plasma exchange (TPE) is used in solid-organ transplant patients to treat antibody-mediated rejection (AMR) by removing donor specific antibodies (DSAs). While ASFA guidelines exist for treating AMR in other solid-organ transplants, no such guidelines exist for small bowel-allograft patients; the benefit of TPE in AMR of small bowel transplant patients has not been studied. Five patients were followed with serial surveillance ileoscopies and allograft biopsies. Tissues were processed using standard protocols (UNMC) for permanent histologic examination. Two H&E stained slides from each biopsy were examined microscopically by gastrointestinal/transplant pathologists for evidence of ACR. To assess for AMR, serial serum DSA levels were obtained via by Luminex LabScreen single antigen bead assay (One Lambda, Canoga Park, CA). Patients were treated with at least five TPE procedures. To determine whether TPE provided benefit, we examined three parameters in the post-apheresis period: DSA presence and strength, histopathologic rejection, and clinical response. All patients developed class I and/or class II
